Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Clinical trial NCT00943072 · COMPLETED
Trial details
- NCT number
- NCT00943072
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-10-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.